Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Deficit)

v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2022   37,442,663      
Beginning Balance at Dec. 31, 2022 $ 1,466 $ 4 $ 127,693 $ (125,791) $ (440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   112,252      
Exercise of common stock options 85   85    
Share-based compensation expense 533   533    
Foreign currency translation adjustment (33)       (33)
Net loss (5,239)     (5,239)  
Ending Balance (in shares) at Mar. 31, 2023   37,554,915      
Ending Balance at Mar. 31, 2023 $ (3,188) $ 4 128,311 (131,030) (473)
Beginning Balance (in shares) at Dec. 31, 2023 37,442,663 48,613,714      
Beginning Balance at Dec. 31, 2023 $ 23,321 $ 5 169,197 (144,962) (919)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   62,535      
Exercise of common stock options 59   59    
Exercise of common stock warrants (in shares)   94,804      
Share-based compensation expense 885   885    
Foreign currency translation adjustment 13       13
Net loss $ (6,499)     (6,499)  
Ending Balance (in shares) at Mar. 31, 2024 48,771,053 48,771,053      
Ending Balance at Mar. 31, 2024 $ 17,779 $ 5 $ 170,141 $ (151,461) $ (906)